ArticleFrontiers in immunology2021

Co-Expression of miR155 or LSD1 shRNA Increases the Anti-Tumor Functions of CD19 CAR-T Cells.

Jing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.